Markets:

Overview

News

Currencies

International

Treasuries

Vanguard Total Stock Market ETF (NY:VTI)

324.59 +0.40 (+0.12%)

Streaming Delayed Price Updated: 11:56 AM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Total Stock Market ETF

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock ↗

February 23, 2026

TD Cowen analyst Joseph Thome’s new price target represents a potential upside of about 23% from AXSM’s current trading levels.

Via Stocktwits

Topics Artificial Intelligence

Smart Move? Institutional Investor Exits Position in This Vanguard ETF ↗

February 23, 2026

A wealth manager recently dumped all of its shares of the Vanguard Russell 1000 ETF.

Via The Motley Fool

Topics ETFs Regulatory Compliance

RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder ↗

February 23, 2026

The company applied for approval of the gene therapy in the treatment of Glycogen Storage Disease Type Ia or Von Gierke disease.

Via Stocktwits

FBIO Shares Rally After Unit Sells Priority Review Voucher For $205 Million: Retail Now Pins Hopes On Gene Therapy ↗

February 23, 2026

Fortress said that its majority-owned unit Cyprium Therapeutics has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher to Sentynl...

Via Stocktwits

Is Microsoft Down? Downdetector Reports Issues With Azure, Outlook, MSFT 365 ↗

February 23, 2026

Microsoft flagged that services that require Multi-Factor Authentication may return gateway timeout errors for users in the U.S.

Via Stocktwits

Eli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost? ↗

February 23, 2026

The new Zepbound KwikPen can be purchased by cash-paying customers through LillyDirect, Eli Lilly’s direct-to-customer website.

Via Stocktwits

ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 1% Pre-Market ↗

February 23, 2026

Net product revenue in the fourth quarter surged 431% to $38.3 million, above estimates of $37.8 million, according to Fiscal.ai data

Via Stocktwits

Palo Alto Networks Removed From Wedbush’s ‘Best Ideas List’ — Here’s Why ↗

February 23, 2026

According to TheFly, Wedbush’s Dan Ives cited investment price discipline as the reason for the removal of PANW from the list.

Via Stocktwits

Topics Artificial Intelligence Government

Nvidia Must Deliver A Blowout To Reassure Investors That AI Trade Is Still Young, Expert Says Ahead Of NVDA's Q4 Results ↗

February 23, 2026

Being at the epicenter of AI, Ken Mahoney hopes that Nvidia will offer clues as to what’s happening in the technology sector.

Via Stocktwits

Topics Artificial Intelligence

How Broad Market ETFs Like VTI Can Support Long-Term Portfolio Stability ↗

February 23, 2026

Diversification is overlooked by many investors, but it can be a powerful tool for building long-term wealth.

Via The Motley Fool

Topics ETFs Economy

DPZ Stock Pops Pre-Market As Domino’s ‘Hungry For More’ Strategy Drives 32nd Straight Year Of International Same-Store Sales Growth ↗

February 23, 2026

The company said that its market share in the U.S. increased by another point, keeping it ahead of the Quick Service Restaurant pizza category.

Via Stocktwits

Topics Government

Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗

February 23, 2026

Gilead Sciences announced an agreement to acquire Arcellx in a $7.8 billion deal.

Via Stocktwits

You Don't Need to Buy Apple Stock. Here's Why ↗

February 23, 2026

The tech giant has been a big winner for years, but there's a simple reason why many investors can leave it out of their portfolios

Via The Motley Fool

2 ETFs Robinhood Retail Investors Favor Over Palantir, Alphabet, Meta, and Netflix Shares ↗

February 22, 2026

It is no wonder, considering this was the best January ever for ETF inflows.

Via The Motley Fool

Topics ETFs

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗

February 20, 2026

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

Via Stocktwits

Topics Intellectual Property Lawsuit

VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗

February 20, 2026

This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December.

Via Stocktwits

ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts ↗

February 20, 2026

ImmunityBio announced that it has partnered with Biopharma and Cigalah and hopes to launch Anktiva across the broader Middle East and North Africa (MENA) region over time.

Via Stocktwits

Lucid Reportedly Lays Off 12% Workforce Amid Gravity SUV Ramp-Up ↗

February 20, 2026

Techcrunch reported on Friday, citing an internal memo, that the layoffs are likely to impact hundreds of employees.

Via Stocktwits

Topics Workforce

GE Stock On Track To Hit All-Time High: Morgan Stanley Calls It A ‘Structural Winner’, Flags 27% Upside ↗

February 20, 2026

Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.

Via Stocktwits

GRAL Stock Slumps After Hours As Trial For Cancer Test Fails To Show Reduction In Late-Stage Diagnoses ↗

February 19, 2026

The trial did not show a statistically significant reduction in Stage III-IV cancer diagnoses, the company said.

Via Stocktwits

Topics Artificial Intelligence Death

ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time ↗

February 19, 2026

The company reported no earnings for the fourth quarter, compared to an analyst estimate of $0.01 per share.

Via Stocktwits

Topics Artificial Intelligence

Tesla CEO Elon Musk Envisions Coffee Shops At Superchargers Manned By Optimus Bots ↗

February 19, 2026

Musk said that the company might consider the idea in response to an X user.

Via Stocktwits

Topics Earnings

Trevian Wealth Management Buys $2.7 Million of Fidelity Nasdaq Composite Index ETF ↗

February 19, 2026

Fidelity Nasdaq Composite Index ETF tracks thousands of U.S.-listed growth and technology stocks for broad market exposure.

Via The Motley Fool

Topics ETFs Stocks

JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B ↗

February 19, 2026

Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale.

Via Stocktwits

CORT Stock Drops After Appeals Court Sides With Teva In Korlym Patent Fight ↗

February 19, 2026

The ruling pertains to Corcept’s Korlym tablets for the treatment of Cushing syndrome.

Via Stocktwits

Topics Intellectual Property

BKNG Stock Falls To Over 16-Month Lows – Brokerages Flag AI-Related Uncertainties ↗

February 19, 2026

Multiple brokerages, including Barclays and Oppenheimer, slashed their price targets despite a better-than-expected fourth quarter print.

Via Stocktwits

Topics Artificial Intelligence

Cassava Sciences Says DOJ Has Closed Probe Into Allegations Around Its Alzheimer’s Program ↗

February 19, 2026

The probes into the company by both the DOJ and the SEC have now been closed.

Via Stocktwits

Topics Regulatory Compliance

This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened? ↗

February 19, 2026

PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.

Via Stocktwits

Topics Emissions Intellectual Property

CVNA Stock Slumps 10% Pre-Market: Wall Street Questions 2026 Visibility, Retail Flags ‘Deterioration’ ↗

February 19, 2026

Multiple brokerages slashed Carvana’s price target after the company’s fourth-quarter earnings fell below Street estimates.

Via Stocktwits

Topics Artificial Intelligence

Amazon Pips Walmart To Become World’s Biggest Company By Revenue ↗

February 19, 2026

Amazon reported revenue of $716.9 billion in the fiscal year 2025, while its retail rival Walmart posted $713.2 billion in revenue during the year.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.